Use of anti-cgrp antibodies and antibody fragments to prevent or inhibit photophobia or light aversion in subjects in need thereof, especially migraine sufferers
Disclosed is a method of inhibiting photophobia or light aversion or precluding the onset of photophobia or photoaversion in a subject in need thereof comprising administering an effective amount of an anti-CGRP antibody or antibody fragment, anti-CGRP receptor antibody or fragment, or a polypeptide...
Saved in:
Main Authors | , , , , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
26.08.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Disclosed is a method of inhibiting photophobia or light aversion or precluding the onset of photophobia or photoaversion in a subject in need thereof comprising administering an effective amount of an anti-CGRP antibody or antibody fragment, anti-CGRP receptor antibody or fragment, or a polypeptide comprising a fragment of CGRP or a CGRP receptor, wherein the antibody or antibody fragment or fragment of CGRP or CGRP receptor reduces or prevents CGRP-associated photophobia or light aversion. |
---|---|
Bibliography: | Application Number: NZ20120732970 |